119 related articles for article (PubMed ID: 7933785)
1. [Effect of indobufen on leukocyte-dependent thrombocyte aggregation in patients with ischemic heart disease].
Liusov VA; Diukov IV; Uteshev DV
Kardiologiia; 1993; 33(4):22-3. PubMed ID: 7933785
[No Abstract] [Full Text] [Related]
2. [Antiaggregation therapy with ibustrin in patients with ischemic heart diseases].
Liusov VA; Diukov IV; Uteshev DB; Fomchenkov IV
Kardiologiia; 1993; 33(4):17-9. PubMed ID: 7933783
[No Abstract] [Full Text] [Related]
3. [Evaluation of morning platelet aggregation in patients with ischemic cardiopathy after evening administration of indobufen].
Craveri A; Lanfredini M; Citella C; Braconaro F; Colombo L
Minerva Cardioangiol; 1988 Sep; 36(9):411-8. PubMed ID: 3226570
[No Abstract] [Full Text] [Related]
4. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
[TBL] [Abstract][Full Text] [Related]
5. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
[TBL] [Abstract][Full Text] [Related]
6. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
[TBL] [Abstract][Full Text] [Related]
7. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
[TBL] [Abstract][Full Text] [Related]
8. Effects of ticlopidine and indobufen on platelet aggregation induced by A23187 and adrenaline in the presence of different anticoagulants.
Cimminiello C; Milani M; Uberti T; Arpaia G; Bonfardeci G
J Int Med Res; 1989; 17(6):514-20. PubMed ID: 2516825
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aspirin and indobufen in healthy volunteers.
Lee JY; Sung KC; Choi HI
Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
Vinazzer H; Fuccella LM
J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
[TBL] [Abstract][Full Text] [Related]
11. Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease.
Wiseman LR; Fitton A; Buckley MM
Drugs; 1992 Sep; 44(3):445-64. PubMed ID: 1382938
[TBL] [Abstract][Full Text] [Related]
12. [Antiaggregating effect of indobufen. Preliminary results of a study of 20 patients].
Andriani A; Chiappetta MG; Mannarino E; Mosiello G; Zampa G; Beni A
Recenti Prog Med; 1986 Dec; 77(12):580-6. PubMed ID: 3563087
[No Abstract] [Full Text] [Related]
13. [Treatment with indobufen of platelet hyperaggregation in a group of patients with vascular diseases].
Barbieri U; Cappelli S; Zaniol P; Righi A; Artusi P; Scorrano M
Minerva Med; 1991; 82(1-2):63-7. PubMed ID: 2000177
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-hematological evaluation of 57 patients undergoing antiaggregant treatment with indobufen].
Andriani A; Mosiello G; Chiappetta MG; Gregori G; Rinaldi P
Recenti Prog Med; 1990 Jan; 81(1):49-53. PubMed ID: 2236828
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufen.
Mamiya S; Hagiwara M; Ishikawa T; Hidaka H
Thromb Res; 1989 Jun; 54(5):447-56. PubMed ID: 2505401
[TBL] [Abstract][Full Text] [Related]
16. [Clinical contribution to the study of indobufen, a new platelet aggregation inhibitor].
Ciammaichella A; Luzi M; Pezzi F; Recchia O
Clin Ter; 1982 Aug; 102(4):387-95. PubMed ID: 6754219
[No Abstract] [Full Text] [Related]
17. Indobufen treatment in type IIA hypercholesterolemic subjects: effects on platelet function and malondialdehyde production.
Tremoli E; Maderna P; Sirtori M; Colli S; Corvi G; Sirtori CR
Pharmacol Res Commun; 1981 Oct; 13(9):847-59. PubMed ID: 7335762
[No Abstract] [Full Text] [Related]
18. [Clinical-experimental studies on the inhibition of thrombocyte function with acetylsalicylic acid and with indobufen].
Vinazzer H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):783-96. PubMed ID: 94870
[TBL] [Abstract][Full Text] [Related]
19. Long-term trial (6 months) of the platelet aggregation inhibitory activity and biological safety of indobufen in cerebrovascular patients.
Mansi D; Majello L; Palma V; De Michele G; Buscaino GA
Acta Neurol (Napoli); 1983 Dec; 5(6):447-55. PubMed ID: 6367383
[No Abstract] [Full Text] [Related]
20. Inhibition of platelet aggregation in man by indobufen (K 3920).
Vittoria A; Laghi Pasini F; Messa GL; Di Perri T; Corvi G; Fuccella LM
J Int Med Res; 1981; 9(1):12-7. PubMed ID: 7202826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
